Anika Therapeutics (ANIK) Consolidated Net Income (2010 - 2025)
Anika Therapeutics (ANIK) posted quarterly Consolidated Net Income of -$1.5 million for Q4 2025, up 92.21% year-over-year from -$785065.7 in Q4 2024, and down 278.37% quarter-over-quarter from $846000.0 in Q3 2025.
Anika Therapeutics (ANIK) Consolidated Net Income (2010 - 2025) Analysis & Trends
Anika Therapeutics (ANIK) has reported Consolidated Net Income for 16 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Consolidated Net Income rose 92.21% year-over-year to -$1.5 million; the TTM figure through Jun 2026 stood at -$663000.0 (up 98.61% YoY), while the FY2025 annual figure was -$901000.0, up 98.11% from the prior year.
- Consolidated Net Income declined to -$1.5 million in Q4 2025 per ANIK's latest filing, from $846000.0 in the prior quarter.
- Across five years, Consolidated Net Income topped out at $16.2 million in Q4 2023 and bottomed at -$28.1 million in Q3 2024.
- Historically, Consolidated Net Income has averaged -$2.3 million across 5 years, with a median of -$2.0 million in 2024.
- On a YoY basis, Consolidated Net Income climbed as much as 411.38% in 2022 and fell as far as 853.99% in 2022.
- Anika Therapeutics' Consolidated Net Income stood at -$3.2 million in 2021, then surged by 411.38% to $10.1 million in 2022, then surged by 60.71% to $16.2 million in 2023, then tumbled by 219.74% to -$19.4 million in 2024, then jumped by 92.21% to -$1.5 million in 2025.
- Business Quant data shows ANIK's Consolidated Net Income at -$1.5 million in Q4 2025, $846000.0 in Q3 2025, and $677000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Anika Therapeutics | 286.20 Mn | 247.78 Mn | 21.24 Mn | 3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.51 Mn |
| Sep 30, 2025 | 846,000.00 |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | -915,000.00 |
| Dec 31, 2024 | -19.38 Mn |
| Sep 30, 2024 | -28.07 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | -2.56 Mn |
| Dec 31, 2023 | 16.18 Mn |
| Sep 30, 2023 | -6.54 Mn |
| Jun 30, 2023 | -2.74 Mn |
| Mar 31, 2023 | -10.31 Mn |
| Dec 31, 2022 | 10.07 Mn |
| Sep 30, 2022 | -4.16 Mn |
| Jun 30, 2022 | -2.84 Mn |
| Mar 31, 2022 | -2.91 Mn |
| Dec 31, 2021 | -3.23 Mn |
| Sep 30, 2021 | 552,000.00 |
| Jun 30, 2021 | 6.53 Mn |
| Mar 31, 2021 | 2.84 Mn |